Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Tularik |
---|---|
Information provided by: | Tularik |
ClinicalTrials.gov Identifier: | NCT00048529 |
This is a clinical research study of T900607-sodium to determine if it is effective and safe in treating gastric cancer and adenocarcinoma of the esophagus. Patients will be treated on a weekly basis with an intravenous injection of the study drug.
Condition | Intervention | Phase |
---|---|---|
Gastric Cancer Esophageal Neoplasms |
Drug: T900607-sodium intravenous |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria
Lab Values (obtained ≤ 7 days prior to study enrollment):
Exclusion Criteria
United States, California | |
Pacific Oncology Associates | |
Los Gatos, California, United States, 95032 | |
Scripps Health Center | |
San Diego, California, United States, 92137 | |
United States, Florida | |
Moffitt Cancer Center | |
Tampa, Florida, United States, 33612 | |
United States, New Mexico | |
University of New Mexico Cancer Research and Treatment Center | |
Albuquerque, New Mexico, United States, 87131 | |
United States, Ohio | |
Ireland Cancer Center | |
Cleveland, Ohio, United States, 44106 |
Study Chair: | Kerrie Boyd |
Study ID Numbers: | T-607-006 |
Study First Received: | November 1, 2002 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00048529 |
Health Authority: | United States: Food and Drug Administration |
adenocarcinoma of the esophagus |
Digestive System Neoplasms Esophageal disorder Gastrointestinal Diseases Esophageal Neoplasms Stomach cancer Carcinoma Digestive System Diseases Stomach Diseases |
Stomach Neoplasms Head and Neck Neoplasms Gastrointestinal Neoplasms Esophageal Diseases Adenocarcinoma Esophageal neoplasm Neoplasms, Glandular and Epithelial |
Neoplasms Neoplasms by Site Neoplasms by Histologic Type |